Development of retmopathy m diabetic (D) children and adolescents. 120 il children ,adolescents,and young adults (66 6and 54 0) ,ased betw.6.5 and 27.5)
0 of which had entered or completed puberty (>F?i?,were subjected to a thorouqh ophtalm.examinati.on including fluorescein angiograpny(FA)and photographic documentation of the right fundus.D duration ranged between 1 and 20 yrs (yroups 1 :I-4.9 y!n=57) ;2:5-,9.9 (37) ;3:10-14:9(19) ; 4:715(7)).l;etabolic control was evaluated using outpatient visit measurements cf glucosu$?ra,post-prand. blood glucose,growth and weight increments,and episodes of severe metabolic derangements. C~htalmosco~y and fundus ~hoto€?r.revealed vascular changes in 3 bb, while 31 documented microangiopathy (Stages i: 1-5 microaneurysms(1~A iII:6-10 IU; III:>ll Ik; 1V:proliferative retinopathy jin 50% of these pat. I"i.easur.ernents of serum thy~vxine (T't) thyroxine binding globulin (TRG) and tl'iiodothyronine (T3) using RIA as well as T3 uptake % (T3 U > f-ee thyroxine index (FT4I) and free T:, index (FTjI) were conducked in 200 healthy Israelj. children. Their age ranaed f~o m 1 to 17 gears. 1L-0 children from the age of 8 years were divijed into five groups accordingto l'anner's puberty stages. There were no significant age related changes in TtiG arid T3U. Linezr regression of serum conc. of T4 T3 and FT4I showed that each decreased significantly (F< C1.001) with age, while FT3I (?id not change significzntly. The correlation with Tanner's staging showed a significant decrease in T4 and TBG conc. after mid-puberty (between stages P2 and P4). T3 however, decrfased only toward the Assessment of plasma 17a-OH-progesterone (17-OHP) provides a valuable aid in the clinical diagnosis and management of congenital adrenal hyperplasia. However, for this to be useful it is necessary to know the normal values. In contrast to the large number of investigations in full term infants, insufficient data are available concerning 17-OHP levels in preterm infants. In full term and in preterm infants cord and peripheral blood 17-OHP levels were determined, using a commercially available RIA-kit (sorin) . The results (in ng/ml 2 S.E.M.) are summarized in the following table. 
Preterm
Increased urinary excretion of 16a-hydroxy-pregnenolone i n newborn i n f a n t s with 21-hydroxylase deficiency.
Peripheral blood (1st week of life) 2.1 % 0.2 (n = 51) Full term 17 2 2 (n = 24) 4.1 2 0.2 (n = 59)
Urinary excretion of t o t a l I&-hydroxypregnenolone (16a-OH-P' 0 ) , pregnanetriol (PT) and 11-oxopregnanetriol (11-0-PT) were determined by c a p i l l a r y gas chromatography i n 18 healthy neonates and 3 newborn i n f a n t s with congenital adrenal hyperplasia (CAH) during t h e f i r s t t h r e e weeks a f t e r b i r t h . In t h e 4th week of l i f e a l l CAH-infants denonstrated s a l t loosing c r i s i s . Mean s t e r o i d excretion i n ,ug/day (healthy i n f a n t s vs. CAH (brackets)) :
Cord blood 31 + 1 (n = 45)
The means found for two groups of infants differ significantly (p < 0.001). No differences were found in 17-OHP concentration between male and female infants. data indicate that the decrease in T4 acd " conc.
are zot o n i y h e to tk.e decrease in TEG conc. before
The determination of urinary excretion of 16a-OH-P'O i s a puberty, hcwever, duzing pu3erty ,TSG might ?la7 a valuable t o o l i n t h e r e l i a b l e detection of 21-hydroxylase more sii?;r.ific;int r o l e in the 5ecrease of thyroid deficiency during t h e f i r s t weeks of l i f e when conventional
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